Vanguard Health Care ETF (NY:VHT)

According to Reuters, UnitedHealth has received four preliminary bids for Banmedica and could set a deadline for binding offers as early as July.

UnitedHealth Reportedly Draws Bids Worth $1B For Banmedica In Latin America Exit ↗

June 09, 2025

Both trials were conducted during the COVID-19 pandemic, a factor the companies said may have influenced the outcomes.

Topics Fraud

Regeneron Stock Drops On Mixed Results For Smoker’s Lung Treatment ↗

May 30, 2025

Merus Stock Soars On Positive Phase 2 Drug Trial Data, Price Target Hikes: Retail’s Thrilled ↗

Topics Government Stocks

May 23, 2025

BofA’s new price target of $92 implies a 121% upside to Merus’s closing share price of $41.6 on Thursday.

A sector-based ETF portfolio provides an effective way to navigate these market rhythms, allowing investors to position their assets for potential outperformance.

Creating A Sector-Based ETF Portfolio ↗

April 19, 2025

RFK Jr.'s Massive Federal Health Workforce Cut Could Take 'Decades To Rebuild,' Warn Experts: 'We Cannot Accurately Assess Whether We Are Truly Making America Healthier' ↗

Topics ETFs

April 14, 2025

Experts raise alarms about Health Secretary Robert F. Kennedy Jr's decision to layoff tens of thousands of federal workers, disrupting critical health data collection and research efforts.

Via Benzinga

Topics Workforce

As Trump Tariffs Spark Panic, Investors Rush Into These 5 'Recession-Proof' ETFs ↗

April 08, 2025

ETFs that provide exposure to sectors that have historically been considered defensive during downturns are now in the limelight.

Via Benzinga

Topics ETFs Government

Best Blue-Chip ETFs To Buy As Donald Trump’s Trade War Escalates ↗

March 30, 2025

Investing in defensive ETFs may be a good way to weather the storm.

Topics ETFs Government World Trade

Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too? ↗

March 28, 2025

Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals ↗

Topics ETFs Economy Government

March 28, 2025

Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue...

HealthEquity Stock Sees Biggest Drop In Over 3 Years On Disappointing Outlook — Retail Doesn't Feel It's All Doom And Gloom ↗

Topics Bankruptcy

March 20, 2025

CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026.

Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors ↗

Topics Earnings Fraud

March 17, 2025

I often discuss highly rated stocks that are part of highly rated sectors. Thus, this time is a departure from the norm. Let's dive into the data for the healthcare sector.

Topics Government

Healthcare Sector Trying To Bounce Back ↗

March 09, 2025

Watchers on Stocktwits expressed optimism about the company’s pipeline and its aim to secure three BLAs over the next three years.

Topics ETFs Stocks / Equities

Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates ↗

March 05, 2025

Healthcare performed terribly in 2023 and 2024, falling while the market was soaring. Year-to-date, the sector has outperformed. Is it time to focus on the stocks and ETFs of this low-Beta sector as...

Is It Time To Shift Focus To Beaten-Down Healthcare Stocks As Volatility Soars? ↗

March 04, 2025

Topics ETFs Stocks / Equities

These Vanguard ETFs Show Where the Smart Money Is Moving Now ↗

March 03, 2025

Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025 ↗

Topics ETFs

March 02, 2025

Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗

Topics Stocks

February 24, 2025

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗

Topics Earnings

February 24, 2025

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Via Benzinga

Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update ↗

February 24, 2025

CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls.

Hims & Hers Hits New Highs On At-Home Lab Testing Plans: Retail Sees More Room To Run, Analysts Divided ↗

February 19, 2025

One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance.

Hims & Hers Stock: More Gains Ahead Or A Pullback? Most Retail Traders Bet On This Path ↗

February 18, 2025

A poll of over 4,000 respondents found that 47% believe the stock will continue its climb past $60, while 44% expect a significant pullback for profit-taking.

US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget ↗

February 11, 2025

A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set for February 21.

Via Benzinga

Prediction: The 2 Best Vanguard Index Funds in January Will Beat the S&P 500 in 2025 ↗

February 02, 2025

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗

Topics Stocks

January 24, 2025

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

Via Benzinga

ETFs In Focus Post UnitedHealth's Mixed Q4 Results ↗

January 18, 2025

UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the...

Topics ETFs Stocks / Equities

Can the 5 Worst-Performing Stock Market Sectors in 2024 Beat the S&P 500 in 2025? ↗

January 09, 2025

S&P 500 Hits 57 All-Time Highs In Record-Breaking 2024: Magnificent 7 Drive 30% Of Nasdaq's Surge ↗

Topics Stocks

December 25, 2024

The year of milestones, 2024, has seen an unperturbed rise in the bull market, we recap 2024's landmark junctures in the U.S. stock market.

Via Benzinga

Topics Stocks

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services ↗

December 19, 2024

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.

Via Benzinga

Why Are These 3 Vanguard ETFs Underperforming the S&P 500 Since Election Day? ↗

November 14, 2024

Stocks in these "safe" sectors are selling off as investors gravitate toward growth.